Leerink Partners Maintains Outperform on Replimune Group, Raises Price Target to $31
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsPrice Target
Leerink Partners analyst Daina Graybosch maintains Replimune Group (NASDAQ:REPL) with a Outperform and raises the price target from $19 to $31.
Leerink Partners analyst Daina Graybosch maintains Replimune Group (NASDAQ:REPL) with a Outperform and raises the price target from $19 to $31.